*Mission*
Elsevier is committed to making genuine contributions to the science and
health communities.
Elsevier. Building Insights. Breaking Boundaries.

 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Elsevier websites
</wps/find/elsevierwebsites.cws_home/elsevierwebsites> | Alerts
</wps/find/home_content.cws_home/alertingservices>
	Elsevier 		

	Product information search 	
	Search all Elsevier sites 	
Search <javascript:submitSearchForm(document.forms['searchForm'])> 	
Advanced Product Search
</wps/find/advproductsearch.cws_home?action=product_search&search=no>

	

Go to Elsevier home page </wps/find/homepage.cws_home>

	
	Products
</wps/find/subject_area_browse.cws_home/?sh1State=-null-SAR-SAA-SAC-SAD-SAF-SA1-SAI-SAJ-SAK-SAQ-SAP-SAB-SAE-SAL-SAN-SAO-SAG-SAH-SAM&sh2State=&allParents=y&showAll=y>
	

	Experimental Cell Research
</wps/find/journaldescription.cws_home/622826/authorinstructions?navopenmenu=-2>
	

	Journal information

	Product description
</wps/find/journaldescription.cws_home/622826/description#description> 	

	Editorial board
</wps/find/journaleditorialboard.cws_home/622826/editorialboard#editorialboard>
	

	Audience </wps/find/journalaudience.cws_home/622826/description#audience> 	

	Abstracting/indexing
</wps/find/journalabstracting.cws_home/622826/abstracting#abstracting> 	

	Subscription information

	Bibliographic and ordering information
</wps/find/journalbibliographicinfo.cws_home/622826/description#bibliographicinfo>
	

	Conditions of sale
</wps/find/journalconditionsofsale.cws_home/622826/conditionsofsale#conditionsofsale>
	

	Dispatch dates
</wps/find/journaldispatchdates.cws_home/622826/dispatchdates#dispatchdates>
	

	Journal-related information

	Contact the publisher
</wps/find/journalcontactpublisher.cws_home/622826/contactpublisher#contactpublisher>
	

	Impact factor
</wps/find/journalimpactfactors.cws_home/622826/description#impactfactors> 	

	Most downloaded articles
<javascript:openWindow("http://top25.sciencedirect.com/?journal_id=00144827","topdownload")>
	

	Other journals in same subject area
</wps/find/products_in_subject_and_group.cws_home/622826> 	

	Related publications
</wps/find/journalrelatedpublications.cws_home/622826/relatedpublications#relatedpublications>
	

	Support & contact </wps/find/supportfaq.cws_home/overview> 	

	About Elsevier </wps/find/intro.cws_home/ataglance> 	

	Select your view
</wps/find/journaldescription.cws_home/622826/authorinstructions?navopenmenu=4>
	

	

			
	
	EXPERIMENTAL CELL RESEARCH	
		
	

*Guide for Authors*

/Experimental Cell Research/ (/ECR/) is dedicated to publishing
manuscripts that significantly advance our understanding of cell and
molecular biology. Examples of areas of interest to /ECR/ are the cell
cycle; gene regulation; chromatin; subcellular organization; signal
transduction; nuclear import-export; intracellular trafficking;
programmed cell death; the dynamics and function of the cytoskeleton,
cell membrane, and extracellular matrix; the biology of meiosis and
mitosis; cell motility and migration; mechanisms of cellular growth
control and differentiation; and cell-cell interaction between cells in
tissues or in culture. Manuscripts in the area of cancer research,
particularly those that address fundamental aspects of cell and
molecular biology, are also welcomed. Reports describing new
experimental techniques and methods or of theoretical work having a
direct bearing on experimental approaches are also appropriate for
inclusion in the journal. Experimental manuscripts will be given the
highest priority and can range from the subcellular to the organism
level, including work on transgenic animals. Purely descriptive work,
including descriptions of RNA or protein expression patterns, is given
lower priority but can be accepted if it provides important new or
unexpected information.

Acceptance of manuscripts will be based on scientific excellence and
priority as judged by editors and reviewers, on relevance to the central
themes of the journal, and on the interest of the results to a broad
readership of cell and molecular biology. A manuscript of high intrinsic
quality may be returned if it seems better suited to a more specialized
journal. Also, manuscripts that present preliminary observations or an
incremental increase in understanding are not encouraged.

*Submission of Manuscripts*

It is a condition of publication that all manuscripts must be written in
clear and grammatical English and be submitted to the Experimental Cell
Research Web site at http://ees.elsevier.com/yexcr). Authors are
requested to transmit the text and art of the manuscript in electronic
form to this address. Minimal exceptions will be allowed. Each
manuscript must also be accompanied by a cover letter outlining the
basic findings of the paper and their significance. Complete
instructions are available at the submission Web site. If you are unable
to provide an electronic version, please contact the editorial office
prior to submission by e-mail: ecr@elsevier.com
<mailto:ecr@elsevier.com>; telephone: (619) 699-6793; or fax: (619)
699-6211.

Authors are encouraged to suggest four competent reviewers in their
field (include telephone number, fax number, and/or e-mail address for
potential reviewers) and may also suggest individuals whom they wish to
have excluded from the review process.

*Acceptable file types.* Once a paper is accepted, /ECR/ cannot use PDF
or PostScript files because they do not allow editing of the text. Most
word-processing packages are acceptable; however, we prefer that authors
use a recent version of Microsoft Word or Corel WordPerfect. Manuscripts
saved with formatting intact are preferred. Rich-text format (.rtf
extension) is acceptable, but plain text (.txt extension) files are
discouraged. Submit each figure as a separate TIFF or EPS file.

Files created in layout programs such as Adobe FrameMaker or PageMaker,
QuarkXPress, and Corel Ventura are unacceptable. Artwork should not be
embedded within the manuscript. It must be supplied in electronic files
separate from the manuscript file.

*Terms.* Original papers only will be considered. Manuscripts are
accepted for review on the understanding that the same work has not been
published, that it is not under consideration for publication elsewhere,
and that its submission for publication has been approved by all of the
authors and by the appropriate authority at the institution where the
work was carried out. Authors must verify the wording of any cited
personal communication with the persons who supplied the information and
obtain approval for the use of their names in connection with the quoted
information or for the citation of unpublished work; written evidence of
such approval should accompany the manuscript. All material published in
/ECR/ represents the opinions of the authors and should not be construed
to reflect the opinions of the Editors or the Publisher.

Upon acceptance of an article, authors will be asked to sign a "Journal
Publishing Agreement" (for more information on this and copyright see
External link http://www.elsevier.com/copyright). Acceptance of the
agreement will ensure the widest possible dissemination of information.
An e-mail (or letter) will be sent to the corresponding author
confirming receipt of the manuscript together with a 'Journal Publishing
Agreement' form or a link to the online version of this agreement.

Subscribers may reproduce tables of contents or prepare lists of
articles including abstracts of internal circulation within their
institutions. Permission of the Publisher is required for resale or
distribution outside the institution and for all other derivative works,
including compilations and translations (please consult External link
http://www.elsevier.com/permissions).

If excerpts from other copyrighted works are included, the author(s)
must obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by
authors in these cases: please consult External link
http://www.elsevier.com/permissions.

Manuscripts can be published in the format of *regular articles.* There
is no strict size limitation on regular articles, although they usually
do not exceed 15,000 words, preceded by an abstract not to exceed 200
words. /ECR/ also publishes *review articles*, which should be between
3000 and 5000 words in length. /ECR/ does not accept unsolicited review
articles unless they are preapproved by the Editor-in-Chief. All review
articles will be subject to review before publication.

*Funding Body Agreements and Policies.* Elsevier has established
agreements and developed policies to allow authors who publish in
Elsevier journals to comply with potential manuscript archiving
requirements as specified as conditions of their grant awards. To learn
more about existing agreements and policies please visit External link
http://www.elsevier.com/fundingbodies.

*Authors' Rights.* As an author you (or your employer or institution)
retain certain rights; for details you are referred to: External link
http://www.elsevier.com/authorsrights.

*Language Services.* Authors who require information about language
editing and copyediting services pre- and post-submission please visit
External link http://www.elsevier.com/locate/languagepolishing or
contact authorsupport@elsevier.com <mailto:authorsupport@elsevier.com>
for more information. Please note Elsevier neither endorses nor takes
responsibility for any products, goods or services offered by outside
vendors through our services or in any advertising. For more information
please refer to our Terms & Conditions External link
http://www.elsevier.com/termsandconditions

*Preparation of Manuscripts*

Manuscripts should be double-spaced throughout. Pages should be numbered
consecutively and organized as follows:

The /Title Page/ (p. 1) should contain the article title, authors' names
and complete affiliations, footnotes to the title, and the address for
manuscript correspondence (including e-mail address and telephone and
fax numbers).

The /Abstract/ (p. 2) must be a single paragraph that summarizes the
main findings of the paper in less than 200 words. After the abstract a
list of up to 10 keywords that will be useful for indexing or searching
should be included.

/The Introduction/ should be as concise as possible, without subheadings.

/Materials and methods/ should be sufficiently detailed to enable the
experiments to be reproduced.

/Results/ and /Discussion/ may be combined and may be organized into
subheadings.

/Acknowledgments/ should be brief and should precede the references.

/References/ to the literature should be cited by number in square
brackets in the text and listed in numerical order at the end. Use the
most recent edition of the Chemical Abstracts Service Source Index for
abbreviations of journal titles. Please note the following examples:

[1] K.H. Tan, W. Hunziker, Compartmentalization of fas and fas ligand
may prevent auto- or paracrine apoptosis in epithelial cells, Exp. Cell
Res. 284 (2003) 281-288.
[2] E.A. Holleran, S. Karki, E.L.F. Holzbaur, The role of the dynactin
complex in intracellular motility, in: K.W. Jeon (Ed.), International
Review of Cytology, Academic Press, San Diego, 1998, Vol. 182, pp. 69-109.
[3] G.N. Stephanopoulos, A.A. Aristidou, J. Nielsen, Metabolic
Engineering: Principles and Methodologies, Academic Press, San Diego, 1998.

Please ensure that the words 'this issue' are added to any references in
the list (and any citations in the text) to other articles in the same
Special Issue.

*Figures.* Number figures consecutively with Arabic numerals. Please
visit our Web site at External link
http://www.elsevier.com/artworkinstructions for detailed instructions on
preparing electronic artwork.

*Color figures.* One color plate will be published free of charge in
each article, provided color is deemed scientifically necessary by the
reviewers and the Editorial Board. Additional color figures will be
charged to the author. However, if together with your accepted article,
you submit usable color figures, then Elsevier will ensure, *at no
additional charge*, that these figures will appear in color on the Web
(e.g., ScienceDirect and other sites) regardless of whether these
illustrations are reproduced in color in the printed version. For color
reproduction in print, you will receive information regarding the costs
from Elsevier after receipt of your accepted article. For further
information on the preparation of electronic artwork, please see
External link http://www.elsevier.com/artworkinstructions. Please note:
Because of technical complications that can arise in converting color
figures to "gray scale" (for the printed version should you not opt for
color in print), please submit in addition usable black-and-white files
corresponding to all the color illustrations.

*Tables* should be numbered consecutively with Arabic numerals in order
of appearance in the text. Type each table double-spaced on a separate
page with a short descriptive title typed directly above and with
essential footnotes below.

*DNA sequences and GenBank accession numbers.* Authors wishing to enable
other scientists to use the accession numbers cited in their papers via
links to these sources should type this information in the following
manner: For each and every accession number cited in an article, authors
should type the accession number in bold, underlined text. Letters in
the accession number should always be capitalized (see example below).
This combination of letters and format will enable the typesetter to
recognize the relevant texts as accession numbers and add the required
link to GenBank's sequences.

/Example:/ GenBank accession nos. _ *AI631510* _, _ *AI631511* _, _
*AI632198* _, and _ *BF223228* _), a B-cell tumor from a chronic
lymphatic leukemia (GenBank accession no. _ *BE675048* _), and a T-cell
lymphoma (GenBank accession no. _ *AA361117* _).

Authors are encouraged to check accession numbers used very carefully.
An error in a letter or number can result in a dead link.

In the final version of the /printed article/, the accession number text
will not appear bold or underlined. In the final version of the
/electronic/ copy, the accession number text will be linked to the
appropriate source in the NCBI databases, enabling readers to go
directly to that source from the article.

*Preparation of Supplementary Material*

Supplementary files offer the author additional possibilities to publish
supporting applications, movies, animation sequences, high-resolution
images, background datasets, sound clips, and more. Supplementary files
supplied will be published online alongside the electronic version of
your article in Elsevier Web products, including ScienceDirect
(http://www.sciencedirect.com). To ensure that your submitted material
is directly usable, please provide data in one of our recommended file
formats. Submit the material in electronic format together with the
article and supply a concise and descriptive caption for each file. For
more detailed instructions, please visit our artwork instruction pages
at External link http://www.elsevier.com/artworkinstructions.

*Proofs*

PDF proofs will be sent by e-mail to the corresponding author. To avoid
delay in publication, only necessary changes should be made, and
corrections should be returned promptly.

*Policy*

It is understood that *novel biological reagents* described in
manuscripts accepted for publication in /ECR/, e.g., DNA and antibodies,
will be made available to scientists in academic research. All novel
genetic sequence information must be deposited with GenBank or the EMBL
database.

*Author Inquiries*

Register for free to receive email updates from the article tracking
service at External link http://www.elsevier.com/trackarticle. The
article tracking service also provides the facility to set up e-mail
alerts to inform you of when an article's status has changed, as well as
detailed artwork guidelines, copyright information, frequently asked
questions, and more. Contact details for questions arising after
acceptance of an article, especially those relating to proofs, are
provided after registration of an article for publication.

*Sponsored Articles*

/Experimental Cell Research/ offers authors or their institutions the
option to sponsor non-subscriber access to their articles on Elsevier's
electronic publishing platforms. For more information please click here
<http://www.elsevier.com/wps/find/authorshome.authors/yexcr>.

	
		

		

		
	
Printer-friendly version <javascript:openPrinterFriendlyPage()>
  Printer-friendly version <javascript:openPrinterFriendlyPage()>

	

		

		
	
	
 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Privacy policy
</wps/find/privacypolicy.cws_home/privacypolicy> | Terms and Conditions
</wps/find/termsconditions.cws_home/termsconditions> | Feedback
</wps/find/feedbackform.cws_home> | A Reed Elsevier
<http://www.reed-elsevier.com> company 	
 Copyright © 2007 Elsevier B.V. </wps/find/homepage.cws_home> All rights
reserved.

	

